Events and Presentations
2026 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting
Members of Immunic’s management and medical teams will attend this meeting in Charlotte, NC. One late-breaking poster and two additional posters have been accepted for presentation. Additionally, the team will be available throughout the event at booth #307.
Late-Breaking Poster Presentation:
- Title: Novel Unified Statistical Analyses for Confirmed Disability Changes In Multiple Sclerosis for Capturing Possible Neuroprotective Effects
- Presenting Author: James Myles, Global Head of Biostatistics at Immunic
- Abstract ID: 11244
- Poster Board Label: LBA14
- Session Date: Thursday, May 28, 2026
- Session Time: 5:00-7:00 pm ET
- Exhibit Hall
Poster Presentations:
- Title: Effect of Vidofludimus Calcium, a Direct Nurr1 Activator and Selective DHODH Inhibitor, on Patient-Reported Outcomes (PRO) in Progressive MS: Data from Phase 2 CALLIPER Trial
- Presenting Author: Julie Korich, Ph.D., Senior Medical Director, Medical Affairs at Immunic
- Abstract ID: 10843
- Poster Board Label: DMT10
- Session Date: Thursday, May 28, 2026
- Session Time: 5:00-7:00 pm ET
- Exhibit Hall B
- Title: Safety and Tolerability of Vidofludimus Calcium, a Direct Nurr1 Activator and Selective DHODH Inhibitor: Data from Phase 2 CALLIPER Trial
- Presenting Author: Alex Lublin, Ph.D., Senior Medical Director, Medical Affairs at Immunic
- Abstract ID: 10995
- Poster Board Label: DMT11
- Session Date: Thursday, May 28, 2026
- Session Time: 5:00-7:00 pm ET
- Exhibit Hall B
